Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Joann, Aaron"'
Publikováno v:
Journal of Cancer, Vol 2, Iss 1, Pp 81-89 (2011)
Purpose: Sodium stibogluconate (SSG), a small molecule inhibitor of protein tyrosine phosphatases, combined with IFN-alpha-2b (IFN-α) inhibited solid tumor cell line growth in vitro. We conducted a phase I clinical trial with SSG plus IFN-α in adva
Externí odkaz:
https://doaj.org/article/fcd7991293204dc1a4077c7f412440e0
Autor:
Claire F. Verschraegen, David S. Hong, Bang Ning Lee, Jennifer J. Wheler, Evan N. Cohen, Razelle Kurzrock, James M. Reuben, Luis H. Camacho, Joann Aaron, Saneese Stephen, Aung Naing, Hui Gao
Publikováno v:
Journal of Cancer, vol 2, iss 1
Journal of Cancer
Journal of Cancer
Purpose: Sodium stibogluconate (SSG), a small molecule inhibitor of protein tyrosine phosphatases, combined with IFN-alpha-2b (IFN-α) inhibited solid tumor cell line growth in vitro. We conducted a phase I clinical trial with SSG plus IFN-α in adva
Autor:
Filip Janku, Merrill S. Kies, David S. Hong, Xuemei Wang, Siqing Fu, Razelle Kurzrock, Aung Naing, Ignacio Garrido-Laguna, Gerald S. Falchook, Joann Aaron
Publikováno v:
Clinical Cancer Research. 16:4031-4037
Purpose: To compare clinical outcomes of metastatic head and neck cancer patients treated in phase I clinical trials with clinical outcomes of those patients who had their last Food and Drug Administration (FDA)–approved therapy in the setting of m
Publikováno v:
The Breast Journal. 15:69-75
Women with breast cancer have become increasingly more involved on a national and local level in advocating for resources to fight cancer. However, in the context of the relationship with their physicians and other cancer caregivers, much remains to
Autor:
Javier Gonzalez, Christopher E. Pelloski, Caterina Giannini, Howard Colman, Kenneth Aldape, Peter C. Burger, Kenneth R. Hess, Janet M. Bruner, Gregory N. Fuller, Joann Aaron, Lauren A. Langford, Li Huang
Publikováno v:
American Journal of Surgical Pathology. 30:657-664
Distinguishing between grade II and grade III diffuse astrocytomas is important both for prognosis and for treatment decision-making. However, current methods for distinguishing between grades based on proliferative potential are suboptimal, making i
Autor:
Joann Aaron, Walter F. Baile
Publikováno v:
Current Opinion in Oncology. 17:331-335
Contemporary oncology practice acknowledges the importance of partnering with the patient and family in dealing with the illness. Patients also value their physicians as important sources of support when they provide information about the illness, en
Autor:
Nageswara R, Madamanchi, Zhao Y, Hu, Fengzhi, Li, Chris, Horaist, Sung-Kwon, Moon, Cam, Patterson, Marschall S, Runge, Johannes, Ruef, Pamela H, Fritz, Joann, Aaron
Publikováno v:
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1576:237-245
Activation of the human protease-activated receptor-1 (PAR-1) by thrombin leads to myriad functions essential for maintaining vascular integrity. Upregulation of PAR-1 expression is considered important in atherosclerosis, angiogenesis and tumor meta
Autor:
Sarina A, Piha-Paul, Sang Joon, Shin, Tribhawan, Vats, Nandita, Guha-Thakurta, Joann, Aaron, Michael, Rytting, Eugenie, Kleinerman, Razelle, Kurzrock
Publikováno v:
Anticancer research. 34(4)
Pre-clinical findings suggest that combination treatment with bevacizumab and temsirolimus could be effective against malignant pediatric central nervous system (CNS) tumors.Six pediatric patients were treated as part of a phase I trial with intraven
Publikováno v:
Cancer treatment reviews. 39(4)
Due to the critical role of heat shock protein 90 (HSP90) in regulating the stability, activity and intracellular sorting of its client proteins involved in multiple oncogenic processes, HSP90 inhibitors are promising therapeutic agents for cancer tr
Autor:
David S. Hong, Razelle Kurzrock, H. Veasey-Rodrigues, Jennifer J. Wheler, E. C. Golden, Joann Aaron, Aung Naing, S. N. Fessahaye, Siqing Fu, Gerald Steven Falchook, Michael S. Ewer, Sijin Wen, Apostolia-Maria Tsimberidou
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 23(11)
Background Cardiac sequelae from oncologic drugs are important in early cancer drug development. Prolongation of the corrected QT interval (QTc) by noncardiac drugs is the most common cause of drug development delays, nonapprovals and postmarketing w